The estimated Net Worth of Gregory T Went is at least $2.44 Million dollars as of 20 March 2019. Gregory Went owns over 6,319 units of Adamas Pharmaceuticals Inc stock worth over $1,449,112 and over the last 11 years Gregory sold ADMS stock worth over $991,613.
Gregory has made over 11 trades of the Adamas Pharmaceuticals Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently Gregory sold 6,319 units of ADMS stock worth $50,489 on 20 March 2019.
The largest trade Gregory's ever made was exercising 204,900 units of Adamas Pharmaceuticals Inc stock on 15 June 2016 worth over $385,212. On average, Gregory trades about 14,254 units every 73 days since 2014. As of 20 March 2019 Gregory still owns at least 176,291 units of Adamas Pharmaceuticals Inc stock.
You can see the complete history of Gregory Went stock trades at the bottom of the page.
Gregory's mailing address filed with the SEC is C/O ADAMAS PHARMACEUTICALS, INC., 2200 POWELL ST, STE 220, EMERYVILLE, CA, 94608.
Over the last 11 years, insiders at Adamas Pharmaceuticals Inc have traded over $26,222,162 worth of Adamas Pharmaceuticals Inc stock and bought 1,128,061 units worth $17,799,399 . The most active insiders traders include Point Partners Llcjay Jeffr..., David L Mahoney und William W. Ericson. On average, Adamas Pharmaceuticals Inc executives and independent directors trade stock every 25 days with the average trade being worth of $254,236. The most recent stock trade was executed by Vijay Shreedhar on 21 June 2021, trading 6,200 units of ADMS stock currently worth $31,992.
Adamas Pharmaceuticals Inc. delivers innovative medicines that reduce the burden of neurological diseases on patients, caregivers and society. The company is a fully integrated company focused on growing a portfolio of therapies to address a range of neurological diseases.
Adamas Pharmaceuticals Inc executives and other stock owners filed with the SEC include: